Developing life-changing vaccines and immunotherapies

Vaxinano is a clinical-stage biotechnology company, and develops a new generation of nasally administered vaccines (STELLAR-NP) that are more efficient and faster to deploy to combat infectious diseases.
Thermostable, adjuvant-free with effective and long-lasting response, our vaccines protect against the most challenging pathogens, such as parasites, viruses or bacteria.